Summary:
We are conducting a clinical research study for patients suffering from Active Moderate to Severe Ulcerative Colitis.
Length of participation is approximately 7 to 17 weeks including 9 to 11 office visits.
Qualified Participants Must:
• Have established diagnosis of Ulcerative Colitis
•
Refrain from taking certain medications during the study including antibiotics and certain other treatments for UC
•
Be able to attend morning visits
Qualified Participants May Receive:
All office visits, medical procedures and Investigational medications or placebo at no cost to participants.